10 Best Stocks to Buy Under $20 According to Jeremy Green’s Redmile Group
In this piece, we will take a look at the ten best stocks to buy under $20 according to Jeremy Green's Redmile Group.
Posts Tagged ‘NASDAQ:IMGN’
Why These 5 Stocks Are in the Spotlight on Monday
In this article, we take a look at five stocks that are in the spotlight on Monday.
10 Cheap Growth Stocks to Buy According to Billionaire Steve Cohen
In this article, we discuss the 10 cheap growth stocks to buy according to billionaire Steve Cohen.
Where Does The Smart Money Stand On ImmunoGen, Inc. (IMGN)?
In this article we will check out the progression of hedge fund sentiment towards ImmunoGen, Inc. (NASDAQ:IMGN) and determine whether it is a good investment right now.
5 Growth Stocks Under $20 in Billionaire Ken Fisher’s Portfolio
In this article, we discuss the 5 growth stocks under $20 in billionaire Ken Fisher's portfolio.
5 Pharmaceutical Stocks to Buy Under $20 According to Jeremy Green’s Redmile Group
In this article, we discuss the 5 pharmaceutical stocks to buy under $20 according to Jeremy Green's Redmile Group portfolio based on Q3 holdings of the fund.
Hedge Funds Are Crazy About ImmunoGen, Inc. (IMGN)
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end...
Hedge Funds Are Crazy About ImmunoGen, Inc. (IMGN)
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their positions at the end of...
Is IMGN Stock A Buy or Sell?
At Insider Monkey, we pore over the filings of nearly 887 top investment firms every quarter, a process we have now completed for the latest reporting period.
Is IMGN A Good Stock To Buy Now?
The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the third quarter, which unveil their equity...
Hedge Funds Are Dipping Their Toes Into ImmunoGen, Inc. (IMGN)
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Did Hedge Funds Make The Right Call On ImmunoGen, Inc. (IMGN) ?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Hedge Funds Have Never Been This Bullish On ImmunoGen, Inc. (IMGN)
In this article we will check out the progression of hedge fund sentiment towards ImmunoGen, Inc. (NASDAQ:IMGN) and determine whether it is a good investment right now.
Hedge Funds Are Dumping ImmunoGen, Inc. (IMGN)
Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through the end of November.
Is ImmunoGen, Inc. (IMGN) A Good Stock To Buy?
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset...
Here’s What Hedge Funds Think About ImmunoGen, Inc. (IMGN)
Russell 2000 ETF (IWM) lagged the larger S&P 500 ETF (SPY) by nearly 9 percentage points since the end of the third quarter of 2018 as investors worried over the possible ramifications...
Is ImmunoGen, Inc. (IMGN) A Good Stock To Buy?
The elite funds run by legendary investors such as David Tepper and Dan Loeb make hundreds of millions of dollars for themselves and their investors by spending enormous resources...
Hedge Fund and Insider Trading News: Steve Eisman, Carl Icahn, Voce Capital, New Residential Investment Corp (NRZ), ImmunoGen, Inc. (IMGN), and More
LONDON (Reuters) - Hedge funds added more bullish positions in crude and fuels in the most recent week in the expectation that positive trade talks between the United States and...
Hedge Funds Are Betting On ImmunoGen, Inc. (IMGN)
Insider Monkey has processed numerous 13F filings of hedge funds and famous investors to create an extensive database of hedge fund holdings.
Hedge Fund and Insider Trading News: T. Boone Pickens, Steve Eisman, ImmunoGen, Inc. (IMGN), Motus GI Holdings Inc (MOTS), VerifyMe Inc (VRME), and More
Legendary oil tycoon T. Boone Pickens has closed his hedge fund, but the octogenarian’s name may live on on the New York Stock Exchange.
Market Movers Today: Electronic Arts Inc. (EA), ImmunoGen, Inc. (IMGN), Juniper Networks, Inc. (JNPR), and More
The poor performance of Electronic Arts Inc.’s “Star Wars Battlefront 2” was in the spotlight on the company’s fiscal third-quarter earnings report on Tuesday, but that...
Wondering What’s Happening in the Financial Markets Today? Take a Look at These 34 Stories!
"Stocks rose on Wall Street on Thursday, capping a wave of declines in major world equity markets triggered by uncertainty over U.S.
32 Major Stories Summarizing What’s Happening in the World of Finance Today
"The S&P 500 and the Nasdaq Composite hit fresh intraday records on Monday as a jump in oil prices to a two-week high lifted Wall Street sentiment.
This Is What You Should Know About The Financial Markets Today
"U.S. equities traded mixed on Wednesday, with IBM sending the Dow Jones industrial average lower and Morgan Stanley leading financials after posting quarterly results.
Here’s What You Need To Know About The Financial Markets Today
"Stocks fell on Thursday after the U.S. dropped "the mother of all bombs" in Afghanistan while bank stocks dropped despite strong earnings from JPMorgan Chase and Citigroup.
Hedge Funds Are Selling ImmunoGen, Inc. (IMGN)
It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity.
Here’s why Microsoft, ImmunoGen, and Three Other Stocks Are Trending on Tuesday
The three major index futures and crude are once again in the red on Tuesday amid Brexit fears.
Here is What Hedge Funds Think About ImmunoGen, Inc. (IMGN)
The elite funds run by legendary investors such as Dan Loeb and David Tepper make hundreds of millions of dollars for themselves and their investors by spending enormous resources...
What’s the Deal With These Four Sinking Stocks?
ImmunoGen Inc. (NASDAQ:IMGN), Vipshop Holdings Limited (NYSE:VIPS), Urban Outfitters Inc. (NASDAQ:URBN), and TerraForm Power Inc.
Nektar Therapeutics (NKTR): Insiders Aren’t Crazy About It But Hedge Funds Love It
Now, according to many of your peers, hedge funds are assumed to be useless, outdated investment vehicles of a forgotten age.
Acorda Therapeutics Inc (ACOR): Insiders Aren’t Crazy About It But Hedge Funds Love It
To many investors, hedge funds are assumed to be bloated, outdated investment tools of a forgotten age.
Viropharma Inc (VPHM): Are Hedge Funds Right About This Stock?
If you were to ask many traders, hedge funds are seen as useless, old investment vehicles of an era lost to time.
Alnylam Pharmaceuticals, Inc. (ALNY): Insiders Aren’t Crazy About It But Hedge Funds Love It
If you were to ask many market players, hedge funds are seen as useless, outdated financial tools of a period lost to current times.
Alnylam Pharmaceuticals, Inc. (ALNY): Here’s What The Smart Money Thinks
Is Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) the right investment to pursue these days? Hedge funds are taking a bullish view.
Seattle Genetics, Inc. (SGEN), Celldex Therapeutics, Inc. (CLDX): This Company Has Potential to Grow
Cancer is the target of a number of different biotech companies. Out of this lot, I consider Seattle Genetics, Inc. (NASDAQ:SGEN) to be one of the star performers.
Immunomedics, Inc. (IMMU), ImmunoGen, Inc. (IMGN): Should You Invest in These Cancer Treatment Biotechs?
Today, cancer is the second leading cause of death in the United States, accounting for nearly a quarter of all deaths in the country.
Seattle Genetics, Inc. (SGEN): A Billion-Dollar Anticancer Technology in the Making
Anticancer drugs typically damage normal cells as well as cancer cells.
ImmunoGen, Inc. (IMGN), Seattle Genetics, Inc. (SGEN), Celldex Therapeutics, Inc. (CLDX): A Trio of Cancer Immunotherapy Innovators
The cancer world has been abuzz after an exciting ASCO conference. Bristol Myers Squibb Co.
Is Nektar Therapeutics (NKTR) Going to Burn These Hedge Funds?
Nektar Therapeutics (NASDAQ:NKTR) was in 8 hedge funds' portfolio at the end of March.
Synta Pharmaceuticals Corp. (SNTA), VeriFone Systems Inc (PAY): 5 of Last Week’s Biggest Losers
Let's start with Synta Pharmaceuticals Corp. (NASDAQ:SNTA).
This Metric Says You Are Smart to Sell ImmunoGen, Inc. (IMGN)
Is ImmunoGen, Inc. (NASDAQ:IMGN) an excellent investment now? Prominent investors are in a bearish mood.
ImmunoGen, Inc. (IMGN), AEterna Zentaris Inc. (USA) (AEZS) – Tackling Cancer: Your Best Investing Ideas
Over the past three months, we've taken a deep dive into the 12 cancer types most likely to be diagnosed in the U.S.
Myriad Genetics, Inc. (MYGN), Roche Holding Ltd. (ROG): Angelina Jolie’s Selfless Act Heightens Breast Cancer Awareness
I admit to not being a big fan of many of her movies -- possibly the only man on the planet who will admit so -- but there's little denying that movie sensation Angelina Jolie...
Hedge Funds Are Selling ImmunoGen, Inc. (IMGN)
At the moment, there are dozens of methods market participants can use to monitor publicly traded companies. Some of the best are hedge fund and insider trading sentiment.
Sarepta Therapeutics Inc (SRPT): FDA Says, “Call Me Maybe”
A lot has been written this week -- at The Fool and elsewhere -- about Sarepta Therapeutics Inc (NASDAQ:SRPT)' update on its meeting with the Food and Drug Administration.
Acorda Therapeutics Inc (ACOR): Insiders Are Dumping, Should You?
Acorda Therapeutics Inc (NASDAQ:ACOR) was in 10 hedge funds' portfolio at the end of the fourth quarter of 2012.
Pfizer Inc. (PFE) & More…a ‘Breakthrough’ May Be on the Way for Breast Cancer Patients
The process of developing a drug from start to finish is incredibly arduous, usually involves around $1 billion in costs, and can take upwards of a decade to complete.
Tackling Cancer: Breast Cancer’s Biggest Current & Upcoming Players – Roche Holding Ltd. (ADR) (RHHBY), AstraZeneca plc (ADR) (AZN), ImmunoGen, Inc. (IMGN)
As I noted two weeks ago, cancer statistics are both staggering and disappointing.
This FDA Approval Is Actually a Big Deal: Dendreon Corporation (DNDN)
As we've learned in recent years, getting an approval from the Food and Drug Administration is only half the battle.
